Christophe Beauloye Selected Research

glycosylated-nitric oxide complex hemoglobin A

3/2022	Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients.
1/2013	Nitrosylated hemoglobin levels in human venous erythrocytes correlate with vascular endothelial function measured by digital reactive hyperemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe Beauloye Research Topics

Disease

10	ST Elevation Myocardial Infarction 01/2022 - 03/2011
10	Cardiomegaly (Heart Hypertrophy) 01/2022 - 07/2008
9	Fibrosis (Cirrhosis) 01/2022 - 07/2013
8	Ischemia 12/2016 - 09/2002
7	Hypertrophy 10/2020 - 04/2006
6	Insulin Resistance 08/2017 - 07/2006
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
5	Heart Failure 10/2020 - 05/2011
4	Sepsis (Septicemia) 01/2021 - 12/2013
4	Hyperglycemia 01/2021 - 10/2014
4	Myocardial Ischemia (Ischemic Heart Diseases) 04/2020 - 04/2009
4	Diabetic Cardiomyopathies 04/2020 - 01/2016
4	Hypoxia (Hypoxemia) 05/2016 - 06/2014
3	COVID-19 03/2022 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 12/2013
3	Thrombosis (Thrombus) 01/2021 - 01/2018
3	Acute Coronary Syndrome 01/2021 - 02/2017
3	Wounds and Injuries (Trauma) 01/2016 - 01/2014
2	Atrial Fibrillation 01/2022 - 10/2020
2	Cicatrix (Scar) 01/2021 - 09/2014
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 06/2011
2	Myocardial Infarction 01/2021 - 02/2015
2	Heart Diseases (Heart Disease) 01/2020 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2013
2	Hemorrhage 10/2017 - 02/2017
2	Hyperemia 08/2017 - 01/2013
2	Infarction (Infarctions) 02/2015 - 09/2014
2	Left Ventricular Dysfunction 12/2013 - 04/2009
2	Acidosis 06/2013 - 09/2002
2	Takotsubo Cardiomyopathy 03/2012 - 06/2008
1	Fibromuscular Dysplasia 01/2022
1	Cardiogenic Shock 01/2022
1	Obesity 01/2022
1	Capillary Leak Syndrome 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Heart Arrest (Cardiac Arrest) 11/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2020
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2019

Drug/Important Bio-Agent (IBA)

13	AMP-Activated Protein KinasesIBA 01/2021 - 12/2006
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2006
6	Insulin (Novolin)FDA Link 01/2022 - 09/2002
6	CollagenIBA 01/2022 - 09/2014
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2013
5	Protein Kinases (Protein Kinase)IBA 01/2021 - 11/2008
5	Protein Isoforms (Isoforms)IBA 01/2016 - 04/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022 - 01/2013
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2013
2	PeroxidesIBA 03/2022 - 08/2017
2	glycosylated-nitric oxide complex hemoglobin AIBA 03/2022 - 01/2013
2	LipidsIBA 01/2021 - 09/2019
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2020
2	Oxidants (Oxidizing Agents)IBA 10/2020 - 01/2018
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020 - 02/2017
2	Acetyl-CoA CarboxylaseIBA 09/2019 - 12/2006
2	Branched-Chain Amino AcidsIBA 01/2018 - 08/2017
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2017 - 09/2002
2	Contraceptive Agents (Contraceptives)IBA 01/2017 - 01/2013
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2016 - 11/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 08/2015
2	NucleotidesIBA 01/2016 - 02/2015
2	Oxygen (Dioxygen)IBA 01/2016 - 08/2015
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2014 - 11/2011
2	Adenosine Monophosphate (AMP)IBA 06/2014 - 12/2013
1	Angiotensin IIIBA 03/2022
1	AldosteroneIBA 03/2022
1	nitrosyl hemoglobin (Hb X)IBA 03/2022
1	ReninIBA 03/2022
1	TubulinIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Connexin 43 (Connexin43)IBA 01/2021
1	ElementsIBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	CD40 Ligand (CD40L)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AntithrombinsIBA 01/2021
1	InterleukinsIBA 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2021
1	CanagliflozinIBA 01/2021
1	cadherin 5IBA 01/2021
1	Aquaporins (Water Channels)IBA 10/2020
1	Amino Acids FDA Link 10/2020
1	calcium phosphateIBA 10/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020
1	Fibroblast Growth Factor-23IBA 10/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020

Therapy/Procedure

14	Therapeutics 10/2021 - 03/2012
4	Percutaneous Coronary Intervention 01/2022 - 03/2011
2	Stents 01/2021 - 01/2020
2	Length of Stay 01/2021 - 06/2013
2	Induced Heart Arrest (Cardioplegia) 05/2016 - 12/2011
1	Catheter Ablation 01/2022
1	Catheters 01/2021